IP Library Granted Patent US 8,362,285
Granted Patent B2
US 8,362,285 · App. 13/010,727 · Granted Jan 29, 2013

Preparation of bile acids and intermediates thereof

Inventors: Achampeta Rathan Prasad (Hyderabad, IN); Roy A. Swaringen, Jr. (Durham, NC); John Gregory Reid (Niskayuma, NY); Robert M. Moriarty (Michiana Shores, IN); Akhila Kumar Sahoo (Bhubaneswar, IN)
Assignee: Kythera Biopharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,362,285
App. No.
13/010,727
Granted
Jan 29, 2013
Kind
B2
Abstract

Synthetic methods for preparing deoxycholic acid and intermediates thereof are provided.

Claims (37)

1. A method for preparing deoxycholic acid or a salt thereof which method comprises:

a) hydrogenation of a compound of formula 129:

with hydrogen so as to provide compound of formula 130:

where P is a hydroxyl protecting group and R is C 1 -C 6 alkyl;

b) contacting compound 130 with lithium aluminum tri-t-butoxy hydride to provide compound 131:

and

c) deprotection and hydrolysis of compound 131 to provide for deoxycholic acid or a salt thereof.

2. The method of claim 1 , wherein P is acetyl and R is methyl.

3. A method for preparing deoxycholic acid or a salt thereof which method comprises:

a) hydrogenation of a compound of formula 129a:

wherein Ac is acetyl, with hydrogen in the presence of 10% palladium on carbon and ethyl acetate to provide compound of formula 130a:

b) contacting compound 130a with lithium aluminum tri-t-butoxy hydride in the presence of tetrahydrofuran to provide compound 131a:

and

c) deacetylation and hydrolysis of compound 131a in the presence of sodium hydroxide and a mixture of tetrahydrofuran and methanol to provide for deoxycholic acid or a salt thereof.

4. The method of claim 3 which further comprises crystallization of deoxycholic acid or a salt thereof as produced in part c).

5. A method for preparing a compound of formula 1.1:

comprising hydrogenation of a compound of formula 1.0:

with H 2 in the presence of a Pd/C catalyst and DMF.

6. The method of claim 5 , wherein the Pd/C catalyst is 10% Pd/C.

7. The method of claim 6 , wherein the compound of formula 1.1 is more than 99% pure.

8. A method for preparing deoxycholic acid (DCA) or a pharmaceutically acceptable salt thereof:

said method comprising

(a) hydrogenation of 9 α-hydroxyandrost-4-en-3,17-dione 1.0 with H 2 in the presence of a Pd/C catalyst to form compound 1.1

(b) reacting compound 1.1 with H 2 SO 4 to form compound 1.2

(c) reacting compound 1.2 with LiA 1 (OtBu) 3 H to form compound 1.3 or a mixture of 1.3 and 1.4

(d) reacting compound 1.3 with Ph 3 PCH 2 CH 3 + Br to form compound 1.5

(e) converting compound 1.5 to a compound of formula 1.6

(f) reacting the compound of formula 1.6 with methylpropiolate of the formula CH≡CC(O)OCH 3 or methyl acrylate of the formula CH 2 ═CHC(O)OCH 3 , in the presence of EtAlCl 2 to form a compound of formula 1.7 wherein, and the dashed line is a single or double bond;

(g) hydrogenation of the compound of formula 1.7 with H 2 to form a compound of formula 1.8

(h) oxidation of the compound of formula 1.8 to form a compound of formula 1.9

(i) hydrogenation of the compound of formula 1.9 with H 2 in the presence of a Pd/C catalyst to form a compound of formula 2.0

(j) reacting the compound of formula 2.0 with LiAl(OtBu) 3 H to form a compound of formula 2.1

and

(k) deacetylation and hydrolysis of the compound of formula 2.1 to form deoxycholic acid or a pharmaceutically acceptable salt thereof.

9. The method of claim 8 which further comprises crystallization of deoxycholic acid or a salt thereof as produced in part (k).

10. The method of claim 8 , wherein the Pd/C catalyst in step (a) is 10% Pd/C.

11. The method of claim 8 , wherein the hydrogenation is carried out in DMF.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Nov 8, 2019
From: KYTHERA BIOPHARMACEUTICALS, LLC; ALLERGAN SALES, LLC
To: ALLERGAN SALES, LLC
Reel/Frame 050963/0068 →
CHANGE OF NAME Recorded Oct 8, 2019
From: KYTHERA BIOPHARMACEUTICALS, INC.
To: KYTHERA BIOPHARMACEUTICALS, LLC
Reel/Frame 050672/0691 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2011
From: PRASAD, ACHAMPETA RATHAN; SWARINGEN, ROY A., JR.; REID, JOHN GREGORY; MORIARTY, ROBERT M.; SAHOO, AKHILA KUMAR
To: KYTHERA BIOPHARMACEUTICALS, INC.
Reel/Frame 026434/0470 →
Priority Claims (1)
GB 0807615.0 · Apr 25, 2008 · national
Continuity (3)
Division 12613969 · Nov 6, 2009
Continuation 12153446 · May 16, 2008
Related Publication 20110152552A1 · Jun 23, 2011